{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T16:08:24Z","timestamp":1786723704243,"version":"build-2736575974"},"reference-count":76,"publisher":"MDPI AG","issue":"8","license":[{"start":{"date-parts":[[2024,8,2]],"date-time":"2024-08-02T00:00:00Z","timestamp":1722556800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Genes"],"abstract":"<jats:p>Cardiac involvement is a major feature of RASopathies, a group of phenotypically overlapping syndromes caused by germline mutations in genes encoding components of the RAS\/MAPK (mitogen-activated protein kinase) signaling pathway. In particular, Noonan syndrome (NS) is associated with a wide spectrum of cardiac pathologies ranging from congenital heart disease (CHD), present in approximately 80% of patients, to hypertrophic cardiomyopathy (HCM), observed in approximately 20% of patients. Genotype\u2013cardiac phenotype correlations are frequently described, and they are useful indicators in predicting the prognosis concerning cardiac disease over the lifetime. The aim of this review is to clarify the molecular mechanisms underlying the development of cardiac diseases associated particularly with NS, and to discuss the main morphological and clinical characteristics of the two most frequent cardiac disorders, namely pulmonary valve stenosis (PVS) and HCM. We will also report the genotype\u2013phenotype correlation and its implications for prognosis and treatment. Knowing the molecular mechanisms responsible for the genotype\u2013phenotype correlation is key to developing possible targeted therapies. We will briefly address the first experiences of targeted HCM treatment using RAS\/MAPK pathway inhibitors.<\/jats:p>","DOI":"10.3390\/genes15081015","type":"journal-article","created":{"date-parts":[[2024,8,2]],"date-time":"2024-08-02T09:34:17Z","timestamp":1722591257000},"page":"1015","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Cardiac Phenotype and Gene Mutations in RASopathies"],"prefix":"10.3390","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1899-8337","authenticated-orcid":false,"given":"Maria Felicia","family":"Faienza","sequence":"first","affiliation":[{"name":"Pediatric Unit, Department of Precision and Regenerative Medicine and Ionian Area, University of Bari \u201cAldo Moro\u201d, 70124 Bari, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9924-4915","authenticated-orcid":false,"given":"Giovanni","family":"Meliota","sequence":"additional","affiliation":[{"name":"Department of Pediatric Cardiology, Giovanni XXIII Pediatric Hospital, 70126 Bari, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0680-5251","authenticated-orcid":false,"given":"Donatella","family":"Mentino","sequence":"additional","affiliation":[{"name":"Pediatric Unit, Department of Precision and Regenerative Medicine and Ionian Area, University of Bari \u201cAldo Moro\u201d, 70124 Bari, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-5112-1497","authenticated-orcid":false,"given":"Romina","family":"Ficarella","sequence":"additional","affiliation":[{"name":"U.O.C. Laboratorio di Genetica Medica, PO Di Venere-ASL Bari, 70012 Bari, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5299-6036","authenticated-orcid":false,"given":"Mattia","family":"Gentile","sequence":"additional","affiliation":[{"name":"U.O.C. Laboratorio di Genetica Medica, PO Di Venere-ASL Bari, 70012 Bari, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ugo","family":"Vairo","sequence":"additional","affiliation":[{"name":"Department of Pediatric Cardiology, Giovanni XXIII Pediatric Hospital, 70126 Bari, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriele","family":"D\u2019amato","sequence":"additional","affiliation":[{"name":"Neonatal Intensive Care Unit, Di Venere Hospital, 70012 Bari, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,8,2]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1002\/ajmg.c.32012","article-title":"The molecular genetics of RASopathies: An update on novel disease genes and new disorders","volume":"190","author":"Tartaglia","year":"2022","journal-title":"Am. J. Med. Genet. Part C Semin. Med. Genet."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1002\/ajmg.c.32015","article-title":"Clinical overview on RASopathies","volume":"190","author":"Zenker","year":"2022","journal-title":"Am. J. Med. Genet. Part C Semin. Med. Genet."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1001\/archpedi.1968.02100020377005","article-title":"Hypertelorism with Turner Phenotype: A New Syndrome with Associated Congenital Heart Disease","volume":"116","author":"Noonan","year":"1968","journal-title":"Am. J. Dis. Child."},{"key":"ref_4","unstructured":"Adam, M.P., Feldman, J., Mirzaa, G.M., Pagon, R.A., Wallace, S.E., Bean, L.J.H., Gripp, K.W., and Amemiya, A. (1993). Noonan Syndrome. Gene Reviews((R)), University of Washington."},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Libraro, A., D\u2019Ascanio, V., Cappa, M., Chiarito, M., Digilio, M.C., Einaudi, S., Grandone, A., Maghnie, M., Mazzanti, L., and Mussa, A. (2021). Growth in Children with Noonan Syndrome and Effects of Growth Hormone Treatment on Adult Height. Front. Endocrinol., 12.","DOI":"10.3389\/fendo.2021.761171"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1038\/gim.2017.249","article-title":"Autosomal recessive Noonan syndrome associated with biallelic LZTR1 variants","volume":"20","author":"Johnston","year":"2018","journal-title":"Genet. Med."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1750-1172-2-4","article-title":"Noonan syndrome","volume":"2","year":"2007","journal-title":"Orphanet J. Rare Dis."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1002\/ajmg.a.62529","article-title":"Genotype-cardiac phenotype correlations in a large single-center cohort of patients affected by RASopathies: Clinical implications and literature review","volume":"188","author":"Leoni","year":"2021","journal-title":"Am. J. Med. Genet. Part A"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1007\/s13402-022-00698-1","article-title":"A comprehensive review of SHP2 and its role in cancer","volume":"45","author":"Asmamaw","year":"2022","journal-title":"Cell. Oncol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1002\/humu.21492","article-title":"SOS1 mutations in Noonan syndrome: Molecular spectrum, structural insights on pathogenic effects, and genotype-phenotype correlations","volume":"32","author":"Lepri","year":"2011","journal-title":"Hum. Mutat."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1007\/s00246-009-9473-7","article-title":"PTPN11 gene mutation and severe neonatal hypertrophic cardiomyopathy: What is the link?","volume":"30","author":"Faienza","year":"2009","journal-title":"Pediatr. Cardiol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.ijcard.2017.07.068","article-title":"Cardiac defects, morbidity and mortality in patients affected by RASopathies. CARNET study results","volume":"245","author":"Calcagni","year":"2017","journal-title":"Int. J. Cardiol."},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Hilal, N., Chen, Z., Chen, M.H., and Choudhury, S. (2023). RASopathies and cardiac manifestations. Front. Cardiovasc. Med., 10.","DOI":"10.3389\/fcvm.2023.1176828"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1002\/bdr2.1670","article-title":"Atypical cardiac defects in patients with RASopathies: Updated data on CARNET study","volume":"112","author":"Calcagni","year":"2020","journal-title":"Birth Defects Res."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.ppedcard.2015.01.002","article-title":"Cardiomyopathies in Noonan syndrome and the other RASopathies","volume":"39","author":"Gelb","year":"2015","journal-title":"Prog. Pediatr. Cardiol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.semcdb.2014.09.013","article-title":"The role of the protein tyrosine phosphatase SHP2 in cardiac development and disease","volume":"37","author":"Lauriol","year":"2015","journal-title":"Semin. Cell Dev. Biol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"3017","DOI":"10.1161\/CIRCULATIONAHA.112.107888","article-title":"Hypoxia Induces Myocardial Regeneration in Zebrafish","volume":"126","author":"Jopling","year":"2012","journal-title":"Circulation"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"4736","DOI":"10.1073\/pnas.0810053106","article-title":"Noonan syndrome cardiac defects are caused by PTPN11 acting in endocardium to enhance endocardial-mesenchymal transformation","volume":"106","author":"Araki","year":"2009","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"H231","DOI":"10.1152\/ajpheart.00665.2011","article-title":"The PTPN11 loss-of-function mutation Q510E-Shp2 causes hypertrophic cardiomyopathy by dysregulating mTOR signaling","volume":"302","author":"Schramm","year":"2012","journal-title":"Am. J. Physiol.-Heart Circ. Physiol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1002\/ajmg.a.36982","article-title":"Rapidly progressive hypertrophic cardiomyopathy in an infant with Noonan syndrome with multiple lentigines: Palliative treatment with a rapamycin analog","volume":"167","author":"Hahn","year":"2015","journal-title":"Am. J. Med. Genet. Part A"},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Ramos-Kuri, M., Meka, S.H., Salamanca-Buentello, F., Hajjar, R.J., Lipskaia, L., and Chemaly, E.R. (2021). Molecules linked to Ras signaling as therapeutic targets in cardiac pathologies. Biol. Res., 54.","DOI":"10.1186\/s40659-021-00342-6"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"16395","DOI":"10.1073\/pnas.1418126111","article-title":"K-RasV14I recapitulates Noonan syndrome in mice","volume":"111","author":"Fabbiano","year":"2014","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1172\/JCI44929","article-title":"MEK-ERK pathway modulation ameliorates disease phenotypes in a mouse model of Noonan syndrome associated with the Raf1(L613V) mutation","volume":"121","author":"Wu","year":"2011","journal-title":"J. Clin. Investig."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.ebiom.2019.03.014","article-title":"New Noonan syndrome model mice with RIT1 mutation exhibit cardiac hypertrophy and susceptibility to \u03b2-adrenergic stimulation-induced cardiac fibrosis","volume":"42","author":"Takahara","year":"2019","journal-title":"eBioMedicine"},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"You, X., Ryu, M.J., Cho, E., Sang, Y., Damnernsawad, A., Zhou, Y., Liu, Y., Zhang, J., and Lee, Y. (2021). Embryonic Expression of Nras(G 12 D) Leads to Embryonic Lethality and Cardiac Defects. Front. Cell Dev. Biol., 9.","DOI":"10.3389\/fcell.2021.633661"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"4353","DOI":"10.1172\/JCI43910","article-title":"Activation of multiple signaling pathways causes developmental defects in mice with a Noonan syndrome-associated Sos1 mutation","volume":"120","author":"Chen","year":"2010","journal-title":"J. Clin. Investig."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"6553","DOI":"10.1093\/hmg\/ddu376","article-title":"New BRAF knockin mice provide a pathogenetic mechanism of developmental defects and a therapeutic approach in cardio-facio-cutaneous syndrome","volume":"23","author":"Inoue","year":"2014","journal-title":"Hum. Mol. Genet."},{"key":"ref_28","first-page":"1046","article-title":"Clinical and functional characterization of a novel RASopathy-causing SHOC2 mutation associated with prenatal-onset hypertrophic cardiomyopathy","volume":"40","author":"Motta","year":"2019","journal-title":"Hum. Mutat."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/BF02082326","article-title":"Unusual combination of congenital heart lesions in a child with Noonan\u2019s syndrome","volume":"3","author":"Lam","year":"1982","journal-title":"Pediatr. Cardiol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1017\/S1047951122002529","article-title":"Noonan syndrome associated with hypoplastic left heart syndrome","volume":"33","author":"Lawrence","year":"2023","journal-title":"Cardiol. Young"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1086\/341528","article-title":"Grouping of multiple-lentigines\/LEOPARD and Noonan syndromes on the PTPN11 gene","volume":"71","author":"Digilio","year":"2002","journal-title":"Am. J. Hum. Genet."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1161\/CIRCULATIONAHA.117.028895","article-title":"Long-Term Outcomes of Hypertrophic Cardiomyopathy Diagnosed during Childhood: Results from a National Population-Based Study","volume":"138","author":"Alexander","year":"2018","journal-title":"Circulation"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/j.amjcard.2007.03.093","article-title":"Prevalence and clinical significance of cardiovascular abnormalities in patients with the LEOPARD syndrome","volume":"100","author":"Limongelli","year":"2007","journal-title":"Am. J. Cardiol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/archdischild-2013-305047","article-title":"Cardiovascular disease in Noonan syndrome","volume":"99","author":"Prendiville","year":"2014","journal-title":"Arch. Dis. Child."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1017\/S104795110001088X","article-title":"Spectrum of valvar abnormalities in Noonan\u2019s syndrome\u2014A pathologic study","volume":"4","author":"Sreeram","year":"2008","journal-title":"Cardiol. Young"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1136\/adc.2006.104547","article-title":"The natural history of Noonan syndrome: A long-term follow-up study","volume":"92","author":"Shaw","year":"2007","journal-title":"Arch. Dis. Child."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1002\/ajmg.c.32014","article-title":"The heart in RASopathies","volume":"190","author":"Delogu","year":"2022","journal-title":"Am. J. Med. Genet. Part C Semin. Med. Genet."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1136\/jmg.40.9.704","article-title":"Correlation between PTPN11 gene mutations and congenital heart defects in Noonan and LEOPARD syndromes","volume":"40","author":"Sarkozy","year":"2003","journal-title":"J. Med. Genet."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/ng1939","article-title":"Gain-of-function SOS1 mutations cause a distinctive form of Noonan syndrome","volume":"39","author":"Tartaglia","year":"2007","journal-title":"Nat. Genet."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1002\/humu.22834","article-title":"Activating Mutations Affecting the Dbl Homology Domain of SOS2 Cause Noonan Syndrome","volume":"36","author":"Cordeddu","year":"2015","journal-title":"Hum. Mutat."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1097\/GIM.0b013e3181772111","article-title":"Adults with genetic syndromes and cardiovascular abnormalities: Clinical history and management","volume":"10","author":"Lin","year":"2008","journal-title":"Genet. Med."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1161\/01.CIR.89.4.1751","article-title":"Independent predictors of long-term results after balloon pulmonary valvuloplasty. Valvuloplasty and Angioplasty of Congenital Anomalies (VACA) Registry Investigators","volume":"89","author":"McCrindle","year":"1994","journal-title":"Circulation"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1053\/j.semtcvs.2018.12.004","article-title":"Early Outcomes of Cardiac Surgery in Patients with Noonan Syndrome","volume":"31","author":"Hemmati","year":"2019","journal-title":"Semin. Thorac. Cardiovasc. Surg."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/0735-1097(93)90727-I","article-title":"Five-year follow-up after balloon pulmonary valvuloplasty","volume":"21","author":"Masura","year":"1993","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1017\/S1047951117002827","article-title":"Results of balloon pulmonary valvoplasty in children with Noonan\u2019s syndrome","volume":"28","author":"Holzmann","year":"2018","journal-title":"Cardiol. Young"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1002\/ccd.30148","article-title":"Supravalvular pulmonary stenosis: A risk factor for reintervention in Noonan syndrome with pulmonary valve stenosis","volume":"99","author":"Abumehdi","year":"2022","journal-title":"Catheter. Cardiovasc. Interv."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1097\/MOP.0000000000000669","article-title":"Cardiovascular disease in Noonan syndrome","volume":"30","author":"Pierpont","year":"2018","journal-title":"Curr. Opin. Pediatr."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1093\/eurheartj\/ehaa554","article-title":"2020 ESC Guidelines for the management of adult congenital heart disease","volume":"42","author":"Baumgartner","year":"2021","journal-title":"Eur. Heart J."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1093\/eurheartj\/ehy798","article-title":"Clinical presentation and survival of childhood hypertrophic cardiomyopathy: A retrospective study in United Kingdom","volume":"40","author":"Norrish","year":"2019","journal-title":"Eur. Heart J."},{"key":"ref_50","doi-asserted-by":"crossref","unstructured":"Monda, E., Rubino, M., Lioncino, M., Di Fraia, F., Pacileo, R., Verrillo, F., Cirillo, A., Caiazza, M., Fusco, A., and Esposito, A. (2021). Hypertrophic Cardiomyopathy in Children: Pathophysiology, Diagnosis, and Treatment of Non-sarcomeric Causes. Front. Pediatr., 9.","DOI":"10.3389\/fped.2021.632293"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.hfc.2017.12.005","article-title":"Clinical Presentation and Natural History of Hypertrophic Cardiomyopathy in RASopathies","volume":"14","author":"Calcagni","year":"2018","journal-title":"Heart Fail. Clin."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1172\/JCI46399","article-title":"RAS signaling pathway mutations and hypertrophic cardiomyopathy: Getting into and out of the thick of it","volume":"121","author":"Gelb","year":"2011","journal-title":"J. Clin. Investig."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1017\/S104795110800320X","article-title":"A standard echocardiographic and tissue Doppler study of morphological and functional findings in children with hypertrophic cardiomyopathy compared to those with left ventricular hypertrophy in the setting of Noonan and LEOPARD syndromes","volume":"18","author":"Cerrato","year":"2008","journal-title":"Cardiol. Young"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.hfc.2021.07.004","article-title":"Hypertrophic Cardiomyopathy in RASopathies: Diagnosis, Clinical Characteristics, Prognostic Implications, and Management","volume":"18","author":"Lioncino","year":"2022","journal-title":"Heart Fail. Clin."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/S0022-3476(99)70088-0","article-title":"Congenital heart diseases in children with Noonan syndrome: An expanded cardiac spectrum with high prevalence of atrioventricular canal","volume":"135","author":"Marino","year":"1999","journal-title":"J. Pediatr."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1038\/s41390-022-02184-8","article-title":"RASopathies and sigmoid-shaped ventricular septum morphology: Evidence of a previously unappreciated cardiac phenotype","volume":"93","author":"Delogu","year":"2023","journal-title":"Pediatr. Res."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1038\/s41390-020-01292-7","article-title":"Genotype-phenotype association by echocardiography offers incremental value in patients with Noonan Syndrome with Multiple Lentigines","volume":"90","author":"Kauffman","year":"2021","journal-title":"Pediatr. Res."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1093\/eurheartj\/ehs397","article-title":"Diagnostic work-up in cardiomyopathies: Bridging the gap between clinical phenotypes and final diagnosis. A position statement from the ESC Working Group on Myocardial and Pericardial Diseases","volume":"34","author":"Rapezzi","year":"2013","journal-title":"Eur. Heart J."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1002\/ajmg.c.10019","article-title":"Costello syndrome: An overview","volume":"117","author":"Hennekam","year":"2003","journal-title":"Am. J. Med. Genet. Part C Semin. Med. Genet."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1002\/ajmg.a.33857","article-title":"Clinical, pathological, and molecular analyses of cardiovascular abnormalities in Costello syndrome: A Ras\/MAPK pathway syndrome","volume":"155","author":"Lin","year":"2011","journal-title":"Am. J. Med. Genet. Part A"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.ijcard.2019.06.073","article-title":"Prevalence and clinical significance of red flags in patients with hypertrophic cardiomyopathy","volume":"299","author":"Limongelli","year":"2020","journal-title":"Int. J. Cardiol."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1017\/S1047951106001247","article-title":"Is sudden cardiac death predictable in LEOPARD syndrome?","volume":"16","author":"Limongelli","year":"2006","journal-title":"Cardiol. Young"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"5057","DOI":"10.1002\/ehf2.13573","article-title":"Clinical presentation and long-term outcomes of infantile hypertrophic cardiomyopathy: A European multicentre study","volume":"8","author":"Norrish","year":"2021","journal-title":"ESC Heart Fail."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1016\/j.jacc.2023.01.012","article-title":"Risk of Sudden Death in Patients with RASopathy Hypertrophic Cardiomyopathy","volume":"81","author":"Lynch","year":"2023","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1161\/CIRCULATIONAHA.120.047235","article-title":"A Validated Model for Sudden Cardiac Death Risk Prediction in Pediatric Hypertrophic Cardiomyopathy","volume":"142","author":"Miron","year":"2020","journal-title":"Circulation"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"131405","DOI":"10.1016\/j.ijcard.2023.131405","article-title":"Sudden cardiac death in childhood RASopathy-associated hypertrophic cardiomyopathy: Validation of the HCM risk-kids model and predictors of events","volume":"393","author":"Boleti","year":"2023","journal-title":"Int. J. Cardiol."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1017\/S1047951117002384","article-title":"Disopyramide use in infants and children with hypertrophic cardiomyopathy","volume":"28","author":"Miller","year":"2018","journal-title":"Cardiol. Young"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1016\/j.amjcard.2015.06.037","article-title":"Surgical Ventricular Septal Myectomy for Patients with Noonan Syndrome and Symptomatic Left Ventricular Outflow Tract Obstruction","volume":"116","author":"Poterucha","year":"2015","journal-title":"Am. J. Cardiol."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1016\/j.healun.2009.05.028","article-title":"Outcomes of pediatric patients with hypertrophic cardiomyopathy listed for transplant","volume":"28","author":"Gajarski","year":"2009","journal-title":"J. Heart Lung Transplant."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"e1299","DOI":"10.1542\/peds.2013-3251","article-title":"Hemostatic abnormalities in Noonan syndrome","volume":"133","author":"Artoni","year":"2014","journal-title":"Pediatrics"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1186\/s13023-021-02122-7","article-title":"RASopathies and hemostatic abnormalities: Key role of platelet dysfunction","volume":"16","author":"Marchetti","year":"2021","journal-title":"Orphanet J. Rare Dis."},{"key":"ref_72","first-page":"741","article-title":"Trametinib: A Targeted Therapy in Metastatic Melanoma","volume":"9","author":"Hoffner","year":"2018","journal-title":"J. Adv. Pract. Oncol."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.1016\/j.jacc.2019.01.066","article-title":"Hypertrophic Cardiomyopathy in Noonan Syndrome Treated by MEK-Inhibition","volume":"73","author":"Andelfinger","year":"2019","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_74","doi-asserted-by":"crossref","unstructured":"Mussa, A., Carli, D., Giorgio, E., Villar, A.M., Cardaropoli, S., Carbonara, C., Campagnoli, M.F., Galletto, P., Palumbo, M., and Olivieri, S. (2021). MEK Inhibition in a Newborn with RAF1-Associated Noonan Syndrome Ameliorates Hypertrophic Cardiomyopathy but Is Insufficient to Revert Pulmonary Vascular Disease. Genes, 13.","DOI":"10.3390\/genes13010006"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1172\/JCI44972","article-title":"Rapamycin reverses hypertrophic cardiomyopathy in a mouse model of LEOPARD syndrome-associated PTPN11 mutation","volume":"121","author":"Marin","year":"2011","journal-title":"J. Clin. Investig."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1002\/ajmg.c.32024","article-title":"New prospectives on treatment opportunities in RASopathies","volume":"190","author":"Gelb","year":"2022","journal-title":"Am. J. Med. Genet. Part C Semin. Med. Genet."}],"container-title":["Genes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2073-4425\/15\/8\/1015\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T15:28:48Z","timestamp":1760110128000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2073-4425\/15\/8\/1015"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,2]]},"references-count":76,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2024,8]]}},"alternative-id":["genes15081015"],"URL":"https:\/\/doi.org\/10.3390\/genes15081015","relation":{},"ISSN":["2073-4425"],"issn-type":[{"value":"2073-4425","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,2]]}}}